Imagine a scenario where a global crisis disrupts the supply of critical medications, leaving the United States scrambling to secure essential drugs due to an overreliance on foreign production. Currently, over half of the pharmaceuticals distributed in the U.S. are manufactured overseas, with a
The pharmaceutical industry is reeling from the announcement of a new US-EU trade agreement that imposes a 15% tariff on European drugs imported into the United States, marking a seismic shift in transatlantic trade relations and raising concerns about cost increases. Unveiled over the weekend,
Setting the Stage: Navigating a High-Stakes Pharmaceutical Landscape In an era where the pharmaceutical industry faces relentless pressure from patent cliffs and geopolitical uncertainties, Merck has unveiled a staggering $3 billion cost-cutting initiative to secure annual savings by the end of
In the intricate web of global industrial production, the chemical intermediates market stands as an indispensable pillar, facilitating the transformation of raw materials into vital products that shape modern life. These compounds serve as essential building blocks in industries ranging from
The contract development and manufacturing organization (CDMO) sector stands at a critical juncture as global economic policies, particularly U.S. tariffs, cast a shadow over various industries. With tariffs often designed to protect domestic markets, their ripple effects could reshape supply
In the intricate world of pharmaceutical regulation, a lingering debate continues to challenge industry standards and scientific rationale, particularly around the mandatory testing for alkyl sulfonate ester contaminants in sulfonate-salt drugs across Europe and the UK. These compounds, flagged as
